High incidence rate of human herpesvirus 6 infection after Bendamustine, Cytarabine, Etoposide and Melphalan conditioning regimen: A monocentric and retrospective study-Reference-Cited by-同舟云学术

High incidence rate of human herpesvirus 6 infection after Bendamustine, Cytarabine, Etoposide and Melphalan conditioning regimen: A monocentric and retrospective study

Published:2021-06-14 Issue: Volume: Page:038-043
ISSN:2581-3870
Container-title:Archives of Clinical Nephrology
language:
Short-container-title:Arch Clin Nephrol

Author:

Simon Favre,Mathieu Sauvezie,Stephane Vigouroux,Reza Tabrizi,Marie-Sarah Dilhuydy,Gaelle Laboure,Margot Robles,Noel Milpied,Kamal Bouabdallah

Publisher

Peertechz Publications Private Limited

Link

https://www.peertechzpublications.com/articles/ACN-7-154.pdf

Reference36 articles.

1. 1. Appelbaum FR (2008) Hematopoietic cell transplantation for non-Hodgkin's lymphoma: yesterday, today, and tomorrow. J Clin Oncol 26: 2927-2929. Link: https://bit.ly/3wi5PN3

2. 2. Gisselbrecht C, Glass B, Mounier N, Singh Gill D, Linch DC, et al. (2010) Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncol 28: 4184-4190. Link: https://bit.ly/35kVQeh

3. 3. Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, et al. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333: 1540-1545. Link: https://bit.ly/2U3H0GF

4. 4. Isidori A, Piccaluga PP, Loscocco F, Guiducci B, Barulli S, et al. High-dose therapy followed by stem cell transplantation in Hodgkin's lymphoma: past and future. Expert Rev Hematol 6: 451-464. Link: https://bit.ly/3zoVuRC

5. 5. Linch DC, Vaughan Hudson B, Anderson L, Vaughan Hudson G (1997) Impact of high-dose salvage therapy (BEAM) on overall survival in younger patients with advanced large-cell lymphomas entered into BNLI trials. Ann Oncol 8: 63-65. Link: https://bit.ly/3cDNgvb